Hawthorn Extract 565 mg
Goals
$25.99 $0.08 per serving
Product analysis
Hawthorn Extract 565 mg offers an affordable botanical aimed at blood-vessel function. Its preparation cannot be assumed to match specific extracts linked with heart-related findings, so its practical benefit remains uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The named hawthorn component does not establish extract quality or equivalence to a defined preparation. Different declared quantities also cannot be combined into one reliable total.
Ingredient Transparency100
The hawthorn amount and form are disclosed. That supports a basic product comparison, though differing declarations should not be added together.
Value For Money100
The labeled serving has a very favorable cost. Affordability does not establish equivalence to a particular hawthorn extract or its effects.
Customer Satisfaction68
The available customer feedback is positive. Only a small review base supports that picture, so it may not represent wider customer experience.
Product Focus73
A single botanical keeps the formula aimed at blood-vessel and heart-related support. Benefits depend on the preparation, and evidence for generic hawthorn remains conflicting.
- Format
Capsule - Container
- 300 Capsule(s)
- Per serving
- $0.08
- Customer rating
- 4.6 · 42 ratings
Goals
Impact
Highest effect
Hawthorn · 424 mg
Hawthorn is associated with blood-vessel tone in the saved findings. However, the supplied research concerns a specific extract in treated heart failure and does not establish routine benefit from generic hawthorn. The 565 mg amount receives substantial recognition in the saved calculation, but it does not identify that studied extract.
How this product is rated for Cardiovascular Support
Ingredient fit95
The main ingredient or declared actives directly relate to the cardiovascular area represented here.
Goal fit
The main ingredient or declared actives directly relate to the cardiovascular area represented here.
Dose adequacy
The declared amount receives partial recognition relative to the saved amount references; this does not establish a proven response at that exposure.
Pathways53
The findings concentrate on blood-vessel tone.
Depth
The findings concentrate on blood-vessel tone.
Breadth
One area reaches substantial coverage, so the contribution remains focused.
Evidence81
Hawthorn research is preparation- and population-specific, limiting what this generic amount establishes.
Evidence strength
Hawthorn research is preparation- and population-specific, limiting what this generic amount establishes.
Studied preparation
The saved findings recognize the eligible preparation or active declaration; this does not remove the ingredient-specific research limitations.
Formulation logic100
The recognized ingredients have no missing required partner or identified conflict in the supplied checks.
Partner coverage
The recognized ingredients can contribute independently or have their required partner; no additional benefit from combining them is established.
Conflicts
No conflict covered by the supplied checks was identified.
Effective doses
All ingredients retained for this check meet its minimum amount criterion, which is not a proven clinical threshold.
Impact
High effect
Hawthorn has been studied in heart-related conditions, but the evidence is conflicting and specific extracts cannot be equated with an ordinary hawthorn product. The saved result includes the declared amount as a limited contribution to blood-vessel function. That finding does not establish treatment benefit or prevention of cardiovascular events for this preparation.
How this product is rated for Heart Health
Ingredient fit95
Hawthorn provides the main relevant ingredient contribution. The declared amounts contribute according to their separate saved references.
Goal fit
Hawthorn is relevant to this goal; the formula's other actives and wider uses affect how focused it is.
Dose adequacy
The relevant ingredients contribute differently according to their declared amounts and preparation-specific references.
Pathways40
Hawthorn provides the strongest saved contribution through blood-vessel lining function. Only blood-vessel lining function meets the saved coverage threshold.
Depth
Hawthorn provides the strongest saved contribution through blood-vessel lining function.
Breadth
Only blood-vessel lining function meets the saved coverage threshold.
Evidence66
Hawthorn supplies a limited evidence contribution; clinical extract findings do not establish ordinary-product equivalence.
Evidence strength
Hawthorn supplies a limited evidence contribution; clinical extract findings do not establish ordinary-product equivalence.
Studied preparation
The ingredients with qualifying amounts meet the saved preparation criteria; this does not establish finished-product efficacy or form superiority.
Formulation logic100
The contributing ingredients meet the saved minimum amount and partner conditions. No configured conflict was identified.
Partner coverage
The contributing ingredients work independently or have their required partners in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for amount contributions meet the minimum criterion, which does not guarantee clinical benefit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn extract (Vitexin) | 141 mg | |
Hawthorn | 424 mg |
Hawthorn (Vitexin) · 141 mg OverallScore79
Each serving contains 141 mg of hawthorn extract standardized to 1.8%, plus 424 mg of hawthorn. The saved facts do not name the marker used for standardization.
How this ingredient is rated
Composition and Label Disclosure68
The extract and second hawthorn ingredient have separate amounts; only the extract has a recorded marker percentage.
Marker and Preparation Disclosure
The 141 mg extract is standardized to 1.8%, with the marker unnamed in the saved facts; no marker percentage is recorded for the 424 mg ingredient.
Species Name Disclosure
A species is recorded for the extract, but the saved facts do not give its name or identify one for the other hawthorn ingredient.
Composition and Label Disclosure
No separate rules were evaluated in this section.
Commercial Price and Usability100
The whole-product serving costs about $0.09, at the lower end of the evaluated serving prices. Different servings may contain different amounts and preparations of hawthorn.
Commercial Price per Labeled Serving
The whole-product serving costs about $0.09, at the lower end of the evaluated serving prices.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.